Oxygenta Pharmaceutical Limited

Equities

SSORGS

INE102E01018

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:55 2024-06-24 EDT 5-day change 1st Jan Change
35.99 INR -0.03% Intraday chart for Oxygenta Pharmaceutical Limited -1.77% +15.50%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Oxygenta Pharmaceutical Limited announced that it has received INR 32 million in funding CI
Oxygenta Pharmaceutical Limited announced that it expects to receive INR 32 million in funding CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Oxygenta Pharmaceutical Limited Appoints Miss. Dolly Mandhan as the Company Secretary of the Company Designated as the Key Managerial Personnel and Compliance Officer CI
Oxygenta Pharmaceutical Limited Announces Board Appointments CI
Oxygenta Pharmaceutical Limited Approves Board Changes CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Oxygenta Pharmaceutical Limited Announces Resignation of Veerendra Babu Rangisetti as Company Secretary and Compliance Officer CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Sunil Vishram Chawda, Manoj Sunil Chawda, Aakanksha M. Chawda and Raghavender Rao Kanuganti made an offer to acquire a 26% stake in Oxygenta Pharmaceutical Limited for approximately INR 130 million. CI
Oxygenta Pharmaceutical Limited announced a financing transaction CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
SS Organics Adopts New Name MT
S.S. Organics Ltd. has Changed its Name to Oxygenta Pharmaceutical Limited CI
S.S. Organics Limited Announces Resignation of Directors CI
S.S. Organics Limited Announces Resignations of Directors CI
S.S. Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
S.S. Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
S.S. Organics Limited announced that it has received INR 40 million in funding CI
S.S. Organics Limited Announces Appointment of Company Secretary and Compliance Officer CI
S.S. Organics Limited Announces Resignation of Vishal R from Company Secretary and Compliance Officer CI
Chart Oxygenta Pharmaceutical Limited
More charts
Oxygenta Pharmaceutical Limited is an India-based company, which is primarily engaged in the manufacturing of bulk drugs and active pharmaceutical ingredients (API). The Company is also engaged in the business of manufacturing all classes and kinds of drugs, including pharmaceutical preparation, and organic fine chemicals. The Company has its manufacturing facilities situated at Survey no. 252/1, Aroor Village, Sadasivapet Mandal, Sangareddy District, Telangana State.
More about the company